GlobalData on MSN
Crystalys Therapeutics begins Phase III trials for gout treatment
The multi-centre, randomised, double-blind RUBY and TOPAZ studies are assessing the therapy’s performance against allopurinol ...
Gout is the most common type of inflammatory arthritis. Eating foods like red meat, alcohol, and shellfish make the symptoms ...
AR882 is an investigational selective uric acid transporter 1 inhibitor. The Food and Drug Administration (FDA) has granted Fast Track designation to AR882 for the treatment of clinically visible ...
SINGAPORE and PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that FDA has designated its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results